Insights on R&D innovation, emerging technologies, competitive strategy, and strategic decision-making.
For 30 years, salmon was the only PDRN source that mattered clinically. That assumption just broke. A December 2025 clinical...
PDRN has become one of the most watched ingredients in regenerative skincare and aesthetic medicine. For years, the competition was...
Two 2026 academic studies gave the cosmeceutical industry the proof it had been waiting on for years: PDRN can cross...
Myopia is no longer a routine refractive error. It is becoming one of the largest pediatric eye health challenges globally,...
The global tampon market is projected to reach $9.4B by 2030, growing at a ~6% CAGR. However, beneath this steady...
The assumption that compressor noise drives HVAC acoustic R&D is no longer accurate. The innovations in duct and airflow management...
The assumption that Saint-Gobain’s materials R&D is still centered on incremental glass and construction upgrades is no longer accurate. Its...
The company’s latest innovation activity shows concentrated work across battery diagnostics, fast-charging thermal management, pack space optimization, and lithium recovery....
The assumption that Sika’s construction chemicals R&D is still centered on conventional sealants and cement additives is no longer accurate....
For 30 years, salmon was the only PDRN source that mattered clinically. That assumption just broke. A December 2025 clinical study confirmed that low-molecular-weight peony...
PDRN has become one of the most watched ingredients in regenerative skincare and aesthetic medicine. For years, the competition was straightforward: who had the purest...
Two 2026 academic studies gave the cosmeceutical industry the proof it had been waiting on for years: PDRN can cross the stratum corneum. One study...
Over 90% of products marketed as “probiotic” cosmetics contain no live microorganisms. Instead, they deliver postbiotics lysates, ferments, metabolites without disclosing this substitution to consumers...
Around 12% of U.S. adults have used a GLP-1 drug such as semaglutide, tirzepatide, or a similar medication, and about 6% are using one today....
More than 35% of new skincare launches in 2024 used probiotics, prebiotics, or postbiotics. Barrier repair and hydration made up about 41% of microbiome cosmetic...
Over 40% of 2024 skincare launches featured microbiome-related ingredients. Yet approximately 90% of products labeled as “probiotic” actually contain postbiotics (ferments, lysates, filtrates) with no...
Cosmetic R&D teams are being asked to build skin microbiome portfolios while one core question remains unresolved: do barrier repair products need live bacteria, or...
An estimated 15 million U.S. adults currently use GLP-1 receptor agonist medications such as semaglutide and tirzepatide, with that figure projected to reach 30 million...
Precision fermentation is moving from early technical promise to commercial scale-up. GFI notes that fermentation-enabled protein production has expanded from a niche area into a...
Get a demo and explore how leading R&D teams use Slate to streamline discovery, stay ahead of competitors, and drive innovation.
